Mycoplasma pneumoniae is increasingly recognized as a common and an important pathogen in community-acquired respiratory tract infections (RTIs) and pneumonia, particularly in school-age children and young adults. To determine the incidence and antibiotic susceptibility of M. pneumoniae at the main hospitals in Riyadh, Saudi Arabia, we studied 552 respiratory samples from patients diagnosed with different clinical diagnosis. The isolation, identification, enumeration and antibiotic resistance test for M. pneumoniae were performed using Pneumofast kit. There were 194 patients (35.1%) with current M. pneumoniae infection, mostly among younger age groups, with pneumonia the most common underlying clinical condition. All tested isolates were susceptible to four antibiotics included in the Pneumofast kit, doxycycline, minocycline, ciprofloxacine and erythromycin. The findings suggest that M. pneumonia infection in Saudi Arabia is more common among younger age groups, and pneumonia is the most common underlying clinical condition among patients with M. pneumoniae infection, that cannot be distinguished from other respiratory infections on the basis of clinical and radiographic diagnosis alone.
INTRODUCTION
Mycoplasma pneumoniae belongs to the family of smallest living prokaryotes, which lacks a cell wall and has sterols in its cell membrane (1) . M. pneumoniae is an important causative organism of respiratory infections in children and young adults. M. pneumoniae infections display a spectrum of symptoms and signs, ranging from asymptomatic infection to severe and potentially fatal pneumonia or extrapulmonary manifestations (2, 3) . M. pneumoniae pneumonia has been reported in 10~40% of cases of community-acquired pneumonia and shows an even higher incidence during epidemics (2, 4) . M. pneumoniae is a small bacterium that can be artificially cultured and is very sensitive to certain antibiotics in in vitro assays. The organism is fastidious and difficult to grow on cultures.
Therefore, diagnosis of infections caused by this organism is usually confirmed with serological tests or polymerase chain reaction-gene amplification techniques (2) . We have the facility to perform Mycoplasma culture in our college laboratory as a new kit. However, as published information concerning M. pneumoniae infections in Saudi Arabia is insufficient (5, 6), I wished to study the incidence and antibiotic susceptibility of culture proven infections caused by this organism at King Saud General Hospital in Saudi Arabia.
MATERIALS AND METHODS

Study subjects
Five hundred fifty two respiratory specimens (sputum, nasopharyngeal aspiration, endotracheal secretion, and bronchoalveolar lavage) for M. pneumoniae culture were obtained from patients with respiratory tract infections seen as inpatients or in the outpatient or emergency departments, King Saud General Hospital, Saudi Arabia. Respiratory specimens were also Gram-stained and cultured for bacteria.
Information collected included patient's data and clinical diagnosis. The study was approved by the local Research Ethics at King Saud General Hospital.
Microbiological method
For this study a commercial kit, Pneumofast (Elitech 
RESULT
A total of 194 respiratory specimens from 552 patients were positive for M. pneumoniae over one year study period.
The base line characteristics of the patients are summarized in Table 1 . Of all specimens, 273 (49.4%) were associated with pneumonia, 112 (20.3%) with upper respiratory tract infections, 63 (11.3%) with bronchitis, and 104 (18.8%)
were suspected tuberculosis.
M. pneumoniae isolated from 194 cases was subjected 
